Discover the only laser on the market for the treatment of chronic low back pain, neck pain and plantar fascitis. Our new FDA market cleared laser has been proven in double-blind, placebo-controlled, randomized, parallel group, multi-center clinical trial to effectively treat this painful condition. 

The participants of the FX 635 Clinical Trial showed a 58% pain reduction at 2 month follow-up evaluation. This trial went on to demonstrate that the FX 635 is successful in the treatment of chronic low back pain. The recent clearance of the FX 635 is groundbreaking for the pain management community and the war on opioids. 

The FX 635 uses low-level laser technology and patented laser diode arms to precisely target pain centers. The body absorbs the light energy, which encourages the cell’s mitochondria to produce more ATP and promotes natural healing within the cell. Because the laser merely stimulates the cells to promote healing naturally, the FX 635 provides pain relief and reduces inflammation with no adverse side effects.

Clinically, the FX 635 has also been a powerful tool in many brain/neurological and learning disorders.